Disorders due to use of volatile inhalants
Definition
Disorders due to use of volatile inhalants are characterised by the pattern and consequences of volatile inhalant use. Volatile inhalants include a range of compounds that are in the gaseous or vapour phase at ambient temperatures and include various organic solvents, glues, gasoline (petrol), nitrites and gases such as nitrous oxide, trichloroethane, butane, toluene, fluorocarbons, ether and halothane. They have a range of pharmacological properties but are predominantly central nervous system depressants, with many also having vasoactive effects. They tend to be used by younger persons and may be used when access to alternative psychoactive substances is difficult or impossible. Volatile Inhalant Intoxication is well recognized. Volatile inhalants have dependence-producing properties and Volatile Inhalant Dependence and Volatile Inhalant Withdrawal is recognized although comparatively uncommon worldwide. Volatile Inhalant-Induced Mental Disorders are described. They may also cause neurocognitive impairment, including Dementia.
Exclusions
10 subordinate codes
6C4B.0Episode of harmful use of volatile inhalants6C4B.1Harmful pattern of use of volatile inhalants6C4B.2Volatile inhalant dependence6C4B.3Volatile inhalant intoxication6C4B.4Volatile inhalant withdrawal6C4B.5Volatile inhalant-induced delirium6C4B.6Volatile inhalant-induced psychotic disorder6C4B.7Certain specified volatile inhalants-induced mental or behavioural disorders4B4YOther specified diseases of the immune system4B4ZDiseases of the immune system, unspecified
Nearby in Disorders due to substance use
6C40Disorders due to use of alcohol6C41Disorders due to use of cannabis6C42Disorders due to use of synthetic cannabinoids6C43Disorders due to use of opioids6C44Disorders due to use of sedatives, hypnotics or anxiolytics6C45Disorders due to use of cocaine6C46Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone6C47Disorders due to use of synthetic cathinones